Replies to post #154044 on Biotech Values

[swampboots]

"Cleveland-Clinic study challenges accepted notions about “personalized” cancer drugs:".................

This is extremely interesting, and exposes the slow insufficient pace of discoveries centering around expressing a clear theory of cancer cell signaling ie. how to significantly modify the on off switch.
Back to square two, square one is probably the gene but exactly where the targeted "nasties" resides and its environment (every variable of measurement) would have to be tested for years, to get to square three? Get me 1000 physicist pronto.